Cargando…

Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria

BACKGROUND: The aim of this study was to compare liver and oncologic lesion standardized uptake values (SUV) obtained through two different reconstruction protocols, GE’s newest clinical lesion detection protocol (Q.Clear) and the EANM Research Ltd (EARL) harmonization protocol, and to assess the cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devriese, Joke, Beels, Laurence, Maes, Alex, Van de Wiele, Christophe, Pottel, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283809/ https://www.ncbi.nlm.nih.gov/pubmed/30523429 http://dx.doi.org/10.1186/s40658-018-0235-6

Ejemplares similares

Principal component analysis of texture features derived from FDG PET images of melanoma lesions
por: Anne-Leen, DeLeu, et al.
Publicado: (2022)

EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program
por: Lasnon, Charline, et al.
Publicado: (2017)

Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria—Which One Is Most Suitable?
por: Rendl, Gundula, et al.
Publicado: (2022)

Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
por: Costelloe, Colleen M., et al.
Publicado: (2010)

Comparison of the EORTC criteria and PERCIST in solid tumors: a pooled analysis and review
por: Kim, Jung Han
Publicado: (2016)

Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review
por: Min, Seon Jeong, et al.
Publicado: (2016)

PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic Review
por: Van de Wiele, Christophe, et al.
Publicado: (2019)

Prevalence of Organic Colonic Lesions by Colonoscopy in Patients Fulfilling ROME IV Criteria of Irritable Bowel Syndrome
por: Paudel, Mukesh Sharma, et al.
Publicado: (2018)

Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis
por: Kim, Hong Deok, et al.
Publicado: (2019)

Lesion Analysis in PERCIST 1.0: Clinical Ease versus Research Requisite—Where Does the Balance Exist?
por: Bhoil, Amit
Publicado: (2023)

Therapy response evaluation with FDG-PET/CT in small cell lung cancer: a prognostic and comparison study of the PERCIST and EORTC criteria
por: Ziai, D., et al.
Publicado: (2013)

FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST
por: Depardon, Edouard, et al.
Publicado: (2018)

Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST
por: Kairemo, Kalevi, et al.
Publicado: (2019)

Are patients fulfilling MET criteria recognized?
por: Hesselfeldt, R, et al.
Publicado: (2009)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST
por: Vogsen, Marianne, et al.
Publicado: (2021)

Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014)

Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using (18)F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCIST
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Impact of amyloid-PET in daily clinical management of patients with cognitive impairment fulfilling appropriate use criteria
por: Triviño-Ibáñez, Eva María, et al.
Publicado: (2019)

Quantitative Comparison of Prone and Supine PERCIST Measurements in Breast Cancer
por: Whisenant, Jennifer G., et al.
Publicado: (2020)

Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET
por: van der Vos, Charlotte S., et al.
Publicado: (2017)

Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria
por: Velez, Erik M., et al.
Publicado: (2020)

Transcriptome Analysis in Renal Transplant Biopsies Not Fulfilling Rejection Criteria
por: Moreso, Francesc, et al.
Publicado: (2020)

Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST
por: Goldfarb, Lucas, et al.
Publicado: (2019)

Do Hungarian multiple sclerosis care units fulfil international criteria?
por: Kokas, Zsófia, et al.
Publicado: (2022)

Impact of respiratory motion correction on lesion visibility and quantification in thoracic PET/MR imaging
por: Gratz, Marcel, et al.
Publicado: (2020)

Small lesion depiction and quantification accuracy of oncological (18)F-FDG PET/CT with small voxel and Bayesian penalized likelihood reconstruction
por: Xu, Lei, et al.
Publicado: (2022)

Comparison of Lesion Detection and Quantification in MAP Reconstruction with Gaussian and Non-Gaussian Priors
por: Qi, Jinyi
Publicado: (2006)

Narrow-band imaging and high-definition white-light endoscopy in patients with serrated lesions not fulfilling criteria for serrated polyposis syndrome: a randomized controlled trial with tandem colonoscopy
por: Riu Pons, Fausto, et al.
Publicado: (2020)

(18)F Sodium Fluoride PET/CT in Patients with Prostate Cancer: Quantification of Normal Tissues, Benign Degenerative Lesions, and Malignant Lesions
por: Oldan, Jorge D., et al.
Publicado: (2016)

Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer
por: Sørensen, Jonas S., et al.
Publicado: (2020)

Quantitation of cancer treatment response by 2-[(18)F]FDG PET/CT: multi-center assessment of measurement variability using AUTO-PERCIST™
por: O, Joo Hyun, et al.
Publicado: (2021)

Nutritional deficits in elderly smokers with respiratory symptoms that do not fulfill the criteria for COPD
por: Obase, Yasushi, et al.
Publicado: (2011)

Response criteria in solid tumors (PERCIST/RECIST) and SUV(max) in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
por: Pierson, Cory, et al.
Publicado: (2018)

Point-spread function reconstructed PET images of sub-centimeter lesions are not quantitative
por: Munk, O. L., et al.
Publicado: (2017)

Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous (18)F-choline PET/MRI for prostate cancer
por: Muehlematter, Urs J., et al.
Publicado: (2018)

Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria
por: Harmanen, Minna, et al.
Publicado: (2023)

Factors That Affect PERCIST-Defined Test-Retest Comparability: An Exploration of Feasibility in Routine Clinical Practice
por: Yuan, Hui, et al.
Publicado: (2015)

CpG Island Methylation in Familial Colorectal Cancer Patients Not Fulfilling the Amsterdam Criteria
por: Kim, Hee Cheol, et al.
Publicado: (2008)

A 27-Year-Old Patient Fulfilling the Diagnostic Criteria of Both CMML and JMML
por: Elghazaly, Assem A., et al.
Publicado: (2016)

A rare case of dicyclomine and mefenamic acid abuse fulfilling criteria of dependence syndrome
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r73pkmp9snhg8ablblcdecnj12